January 29, 2020
CB2 Insights is pleased to announce the appointment of Tom Brogan, as an independent director to CB2’s Board of Directors.
January 28, 2020
CB2 Insights announces it has completed all payment obligations for the June 2019 acquisition of New Jersey Alternative Medicine.
January 14, 2020
Partnership Underway to Develop Extensive Protocols and Submissions for US Food & Drug Administration to Uncover Safety and Efficacy for...
December 16, 2019
CB2 Insights announced that it will begin a prospective trial with GL Brands through its hemp brand and key operating...
December 12, 2019
CB2 Insights announced its core technology platform, Sail, is now primed for streamlining and aggregating disparate healthcare data systems.
December 11, 2019
CB2 Insights announces a warrant exercise incentive program which has been implemented to encourage the exercise of the Company’s outstanding...
December 3, 2019
CB2 Insights (CSE:CBII, OTCQB:CBIIF) announced that it is partnering with Licensed Producer FCM Global.